Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials

by Ahmed, Rosina , Hlauschek, Dominik , Thompson, Alastair M. , Dodwell, David , Kaidar-Person, Orit , Lee, Han-Byoel , de Boniface, Jana , Chatterjee, Sanjoy , Sepulveda, Karla A. , Spillane, Andrew J. , McIntosh, Stuart A. , Avery, Kerry , Cowan, Katherine , Potter, Shelley , Wright, Jean L. , Richardson, Andrea L. , Finestone, Sandra , Dubsky, Peter , Federmann, Jingjing , Wittmann, Philipp , Zdenkowski, Nicholas , Meyn, Anne , MacKenzie, Mairead , Iwata, Hiroji , Gnant, Michael , Poortmans, Philip , Poulakaki, Fiorita , Jiang, Michael Y. , Werutsky, Gustavo

in 631/67/1347 / 692/308/2779 / 692/308/409 / Biomedical and Life Sciences / Biomedicine / Breast cancer / Cancer and Oncology / Cancer och onkologi / Cancer Research / Cancer therapies / Cell Biology / Chemotherapy / Clinical trials / Human Genetics / Medical research / Oncology / Radiation therapy / Stakeholders / Surgeons / Surgery / Teaching hospitals

2025

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials

2025

Confirm

Do you wish to request the book?

A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials

2025

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials

Ahmed, Rosina,

Hlauschek, Dominik,

Thompson, Alastair M.,

Dodwell, David,

Kaidar-Person, Orit,

Lee, Han-Byoel,

de Boniface, Jana,

Chatterjee, Sanjoy,

Sepulveda, Karla A.,

Spillane, Andrew J.,

McIntosh, Stuart A.,

Avery, Kerry,

Cowan, Katherine,

Potter, Shelley,

Wright, Jean L.,

Richardson, Andrea L.,

Finestone, Sandra,

Dubsky, Peter,

Federmann, Jingjing,

Wittmann, Philipp,

Zdenkowski, Nicholas,

Meyn, Anne,

MacKenzie, Mairead,

Iwata, Hiroji,

Gnant, Michael,

Poortmans, Philip,

Poulakaki, Fiorita,

Jiang, Michael Y.,

Werutsky, Gustavo

2025

Overview

Accurate information about locoregional breast cancer treatments following neoadjuvant systemic therapy (NST) is essential for meaningful interpretation of oncological outcomes but reporting is currently poor. We developed a core outcome set (COS) to improve the quality and consistency of locoregional outcome reporting in breast cancer NST trials. The COS was developed in three phases according to COS-STAD guidance, with the generation of a list of relevant outcome domains, prioritisation of outcomes through two rounds of an international online multi-stakeholder Delphi survey and a consensus meeting. 159 unique locoregional outcomes were classified into 101 outcome domains for inclusion in the Delphi survey, which was completed by 470 international professionals. The final 15-item COS, which included the pre-NST surgical plan, details of surgery performed following completion of treatment and details of radiation therapy, was agreed at an in-person consensus meeting. Widespread COS implementation will improve the quality and value of future NST trials.

Share this book

Add to My Shelf

Publisher

Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio

Subject

631/67/1347

/ 692/308/2779

/ 692/308/409

/ Biomedical and Life Sciences

/ Biomedicine

/ Breast cancer

/ Cancer and Oncology